LT2699545T - Nauji amino-pirolino dariniai ir jų naudojimas metabolinio sindromo prevencijai ir (arba) gydymui - Google Patents

Nauji amino-pirolino dariniai ir jų naudojimas metabolinio sindromo prevencijai ir (arba) gydymui

Info

Publication number
LT2699545T
LT2699545T LTEP12722423.6T LT12722423T LT2699545T LT 2699545 T LT2699545 T LT 2699545T LT 12722423 T LT12722423 T LT 12722423T LT 2699545 T LT2699545 T LT 2699545T
Authority
LT
Lithuania
Prior art keywords
prevention
treatment
metabolic syndrome
novel amino
pyrroline derivatives
Prior art date
Application number
LTEP12722423.6T
Other languages
English (en)
Inventor
Pascal Bousquet
Jean Daniel EHRHARDT
Lyne FELLMANN
Vincent GASPARIK
Hugues GRENEY
Mohamed HADJERI
André Mann
Nathalie NIEDERHOFFER
Stephan Schann
Original Assignee
Université De Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1153375A external-priority patent/FR2974364B1/fr
Application filed by Université De Strasbourg filed Critical Université De Strasbourg
Publication of LT2699545T publication Critical patent/LT2699545T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP12722423.6T 2011-04-19 2012-04-17 Nauji amino-pirolino dariniai ir jų naudojimas metabolinio sindromo prevencijai ir (arba) gydymui LT2699545T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1153375A FR2974364B1 (fr) 2011-04-19 2011-04-19 Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique
FR1251302 2012-02-13
PCT/FR2012/050835 WO2012143660A1 (fr) 2011-04-19 2012-04-17 Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique

Publications (1)

Publication Number Publication Date
LT2699545T true LT2699545T (lt) 2016-09-26

Family

ID=46146922

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP12722423.6T LT2699545T (lt) 2011-04-19 2012-04-17 Nauji amino-pirolino dariniai ir jų naudojimas metabolinio sindromo prevencijai ir (arba) gydymui

Country Status (17)

Country Link
US (1) US9303019B2 (lt)
EP (1) EP2699545B1 (lt)
JP (1) JP5986625B2 (lt)
CN (1) CN103619814B (lt)
CA (1) CA2833339C (lt)
CY (1) CY1118117T1 (lt)
DK (1) DK2699545T3 (lt)
ES (1) ES2588059T3 (lt)
HR (1) HRP20161024T1 (lt)
HU (1) HUE030432T2 (lt)
LT (1) LT2699545T (lt)
PL (1) PL2699545T3 (lt)
PT (1) PT2699545T (lt)
RS (1) RS55061B1 (lt)
SI (1) SI2699545T1 (lt)
SM (1) SMT201600284B (lt)
WO (1) WO2012143660A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015007710A (es) * 2012-12-19 2015-09-23 Bayer Cropscience Ag Indanilcarboxamidas difluorometil-nicotinicas.
WO2023084054A1 (en) 2021-11-12 2023-05-19 3Z Ehf Treatment of adhd using selective binders of the 11-imidazoline receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670859A1 (de) 1967-04-24 1971-03-11 Bayer Ag Verfahren zur Herstellung von 2-Phenyl-imino-1-azacycloalkanen
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines
US4533739A (en) * 1982-10-12 1985-08-06 G. D. Searle & Co. 2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
ES2756499T3 (es) 2009-10-06 2020-04-27 Allergan Inc Derivados de 2H-pirrol-5-amina como moduladores de receptor alfa adrenérgico
CN102666484A (zh) 2009-10-21 2012-09-12 阿勒根公司 肾上腺素能受体调节剂

Also Published As

Publication number Publication date
US9303019B2 (en) 2016-04-05
JP2014514316A (ja) 2014-06-19
EP2699545B1 (fr) 2016-05-25
JP5986625B2 (ja) 2016-09-06
ES2588059T3 (es) 2016-10-28
PT2699545T (pt) 2016-08-30
SMT201600284B (it) 2016-11-10
CA2833339A1 (fr) 2012-10-26
CN103619814A (zh) 2014-03-05
HUE030432T2 (en) 2017-05-29
PL2699545T3 (pl) 2017-01-31
EP2699545A1 (fr) 2014-02-26
SI2699545T1 (sl) 2016-12-30
US20140045910A1 (en) 2014-02-13
HRP20161024T1 (hr) 2016-11-04
DK2699545T3 (en) 2016-08-29
CA2833339C (fr) 2020-09-15
CY1118117T1 (el) 2017-06-28
WO2012143660A1 (fr) 2012-10-26
RS55061B1 (sr) 2016-12-30
CN103619814B (zh) 2016-01-20

Similar Documents

Publication Publication Date Title
HRP20181364T8 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
EP2847152A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF METABOLIC SYNDROME
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
RS55927B1 (sr) Fenil-3-aza-biciklo[3.1.0]heks-3-il-metanoni i njihova primena kao lek
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
EP2740729A4 (en) QUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND, AND USE OF THE DERIVATIVE IN THE PREPARATION OF A MEDICAMENT
LT2854910T (lt) Ceramido lygiai infekcijos gydymo ir prevencijos metu
IL233875A (en) Preparation and use for the treatment of anal fissures
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER
RS55061B1 (sr) Novi derivati amino-pirolina i njihova upotreba u prevenciji i/ili lečenju metaboličkog sindroma
ZA201503266B (en) Pyidone derivatives and uses thereof in the treatment of tuberculosis
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
PL2702033T3 (pl) Zastosowanie soli 3-karboksy-N-etylo-N,N-dimetylopropano-1-amoniowych do leczenia choroby układu krążenia
GB201208850D0 (en) Tri-subsituted glycerol compounds for use in the treatment of clinically isolated syndrome and/or multiple sclerosis
PL2771016T3 (pl) Prymycyna i jej składniki do zastosowania w leczeniu lub zapobieganiu infekcjom powodowanym przez określone patogeny
ZA201600894B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes
ZA201307614B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
PT2389936E (pt) Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca